August 2021, Greenville, N.C. – Metrics Contract Services, the contract pharmaceutical development and manufacturing division of Mayne Pharma, welcomes Anshul Gupte, PhD as Senior Director, Scientific and Technical Affairs.
In that capacity, Anshul will be responsible for technical and scientific oversight of client projects. He will work across various functional teams in RFP considerations and scope of work development, proposal delivery, client and prospective client meetings, and contribute to the company’s thought leadership agenda.
Anshul reports to John Ross, President of Metrics Contract Services, who said: “Anshul already has a rich history with Metrics and Mayne Pharma. In this role, he will guide the alignment of MCS as a science driven CDMO focused on providing concept to commercialization services to customers.”
The vision for this role is to elevate the scientific basis on which Metrics partners with clients throughout their clinical development journey. Metrics accomplishes this goal by working closely with clients and interpreting results against the program goals to optimize the development pathway on an on-going basis. This will lead to a robust, reproducible and scalable process as well as quality regulatory drug product filing. The Metrics team believes clients benefit when working with the company as a scientific partner in addition to the high-quality manufacturing partner they see today.
Most recently Anshul served as Senior Director, Drug Product Development for Mayne Pharma in Australia. Previously he worked with Metrics Contract Services in Greenville as Director of Pharmaceutical Development.
Anshul holds a Bachelor of Pharmacy from the RGPV University, Bhopal, India, a Master of Science in Pharmaceutical Sciences from Temple University, and a Doctorate in Pharmaceutical Sciences from the University of Kentucky.